Identification of a novel peptide ligand for the cancer-specific receptor mutation EGFRvIII using high-throughput sequencing of phage-selected peptides
Por um escritor misterioso
Descrição
Pharmaceutics, Free Full-Text
Identification and characterization of a novel peptide ligand of epidermal growth factor receptor for targeted delivery of therapeutics - Li - 2005 - The FASEB Journal - Wiley Online Library
Sequence-activity relationship (SAR) analysis of a cyclic tumor
Identification of a novel peptide ligand for the cancer-specific receptor mutation EGFRvIII using high-throughput sequencing of phage-selected peptides
Frontiers Highly Specific and Effective Targeting of EGFRvIII-Positive Tumors with TandAb Antibodies
Identification of a novel peptide ligand for the cancer-specific receptor mutation EGFRvIII using high-throughput sequencing of phage-selected peptides
An amber obligate active site-directed ligand evolution technique for phage display
(PDF) Highly Specific and Effective Targeting of EGFRvIII-Positive Tumors with TandAb Antibodies
The screening, identification, design and clinical application of tumor- specific neoantigens for TCR-T cells, Molecular Cancer
Novel EGFR-targeted strategy with hybrid peptide against oesophageal squamous cell carcinoma
Novel Regioselective Approach to Cyclize Phage-Displayed Peptides in Combination with Epitope-Directed Selection to Identify a Potent Neutralizing Macrocyclic Peptide for SARS-CoV-2
Identification and characterization of a novel peptide ligand of epidermal growth factor receptor for targeted delivery of therapeutics - Li - 2005 - The FASEB Journal - Wiley Online Library
Neoantigens: promising targets for cancer therapy
Identification of a novel peptide ligand for the cancer-specific receptor mutation EGFRvIII using high-throughput sequencing of phage-selected peptides
Fluorescence imaging of a HER2 positive (pH7-2) and negative (Ph-34)
de
por adulto (o preço varia de acordo com o tamanho do grupo)